Treatment of Chronic Haemophilic Synovitis with PRP: Clinical and In Vitro Studies
International Journal of Molecular Sciences · 23.08.2024 · 25 (17) · 9140
DOI: 10.3390/ijms25179140 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 23.08.2024. Verfasst von Horacio Caviglia und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Argentine Catholic University, Buenos Aires C1032ABS, Argentina. Hauptthemen laut MEDLINE: Synovitis, Platelet-Rich Plasma, Hemophilia A. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Intra-articular blood, iron and hemosiderin, hydroxyl radical cytokines, and neo-angiogenesis cause synovial inflammation, which leads to cartilage and joint damage. Platelet-rich plasma (PRP) inhibits most of the mediators that produce and maintain synovitis. We compile here our work showing the clinical effectiveness of intra-articular PRP injections and their potential role in stopping articular cartilage damage due to bleeding and its possible repair. A total of 116 joints, including knees (63%), elbows (19.8%), and ankles (17.2%), were treated with intra-articular injections of PRP. Moreover, we also show here the number of extracellular DNA traps (ETs) and the PRP effect in the synovial fluid of patients at the time of treatment and six months after. Clinically, it is demonstrated that PRP is effective in reducing bleeding episodes (p < 0.001) and pain (p < 0.0001) and improving the hemophilia joint health score (HJHS) (p < 0.001) at one year of follow-up. Furthermore, our results demonstrate that PRP inhibits ET formation in vitro and reconstitutes the immune system’s cellular components in the synovial fluid of patients after treatment. We conclude that PRP can be considered an effective, safe, and easy treatment for hemophilic synovitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine, Argentine Catholic University, Buenos Aires C1032ABS, Argentina.
- Haemophilia Foundation, Buenos Aires 3485, Argentina.
- Department of Traumatology, Juan A. Fernàndez Hospital, Buenos Aires 3356, Argentina.
- Laboratory of Experimental Thrombosis, Institute of Experimental Medicine-CONICET, National Academy of Medicine, Buenos Aires C1032ABS, Argentina.
- Department of Clinical, Surgical, Diagnostic and Pediatric Sciences, University of Pavia, 27100 Pavia, Italy.
- Orthopedics and Traumatology Clinic, IRCCS Policlinico San Matteo Foundation, 27100 Pavia, Italy.
ORCID-Profile: María Eulalia Landro, Paula Oneto, Micaela Berni, Laura Caliogna, Eugenio Antonio Carrera Silva
Zitieren
APA
Caviglia, H., Landro, M. E., Oneto, P., Cambiaggi, G., Galatro, G., Berni, M., Caliogna, L., Carrera Silva, E. A., & Pasta, G. (2024). Treatment of Chronic Haemophilic Synovitis with PRP: Clinical and In Vitro Studies. International Journal of Molecular Sciences, 25(17), 9140. https://doi.org/10.3390/ijms25179140
Vancouver
Caviglia H, Landro ME, Oneto P, Cambiaggi G, Galatro G, Berni M, et al. Treatment of Chronic Haemophilic Synovitis with PRP: Clinical and In Vitro Studies. International Journal of Molecular Sciences. 2024;25(17):9140. doi:10.3390/ijms25179140
BibTeX
@article{Caviglia2024,
author = {Caviglia, Horacio and Landro, María Eulalia and Oneto, Paula and Cambiaggi, Guillermo and Galatro, Gustavo and Berni, Micaela and Caliogna, Laura and Carrera Silva, Eugenio Antonio and Pasta, Gianluigi},
title = {Treatment of Chronic Haemophilic Synovitis with PRP: Clinical and In Vitro Studies},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {17},
pages = {9140},
doi = {10.3390/ijms25179140}
}
EUVIMED